Glucagon: the effects of its excess and deficiency on insulin action

Nutrition, Metabolism, and Cardiovascular Diseases : NMCD
C G FanelliG B Bolli

Abstract

To review the role that glucagon plays in physiology, physiopathology and clinical medicine. Glucagon assays employing specific radioimmunoassay (RIA) techniques are now widely used to characterize pathologic conditions where the effect of the excess or deficiency of glucagon on insulin actions might play a role. Glucagon excess counteracts the action of insulin on glucose metabolism by stimulating glycogenolysis and gluconeogenesis. Aside from glucagon excess in association with glucagonoma, glucagon excess is found in several metabolic disturbances. In diabetes mellitus, hyperglycaemia is the consequence of the glycogenolytic and gluconeogenic effects of glucagon excess occurring in the setting of a relative insulin deficiency (i.e. Type 2 diabetes), whereas excess of glucagon and absent insulin levels are typical features of diabetic ketoacidosis. Although plasma glucagon levels of patients with diabetes are usually increased relative to the prevailing plasma glucose concentrations, it is a paradox that in those patients glucagon levels fail to rise when hypoglycaemia develops. Since glucagon release is considered the primary defence against insulin-induced hypoglycaemia, the defective response of glucagon to hypoglycaemia m...Continue Reading

References

Jun 1, 1979·Diabetologia·P J Lefebvre, A S Luyckx
May 1, 1978·Archives of Disease in Childhood·L A KolleeR M Wilms
Dec 1, 1976·The Journal of Clinical Investigation·A D CherringtonW W Lacy
Mar 1, 1992·Diabetes Care·A Consoli
Feb 1, 1990·The Journal of Clinical Endocrinology and Metabolism·M S WuG M Reaven
Feb 1, 1991·The Journal of Clinical Endocrinology and Metabolism·M D JensenJ M Miles
Sep 1, 1989·Diabetes·P E CryerR S Sherwin
Feb 1, 1987·The Journal of Clinical Investigation·S Del PratoR A DeFronzo
Jun 25, 1986·Nucleic Acids Research·J W White, G F Saunders
Oct 1, 1971·The Journal of Clinical Investigation·W A MüllerR H Unger
Jun 18, 1981·The New England Journal of Medicine·R H Unger, L Orci
Jun 25, 1981·The New England Journal of Medicine·R H Unger, L Orci
Sep 30, 1993·The New England Journal of Medicine·UNKNOWN Diabetes Control and Complications Trial Research GroupC Siebert
Aug 1, 1993·Diabetes Care·B V Wiethop, P E Cryer
Jan 24, 1998·Metabolism: Clinical and Experimental·J W FrankR A Rizza
Mar 10, 2001·The Journal of Clinical Endocrinology and Metabolism·E BertinE Hagström-Toft
Oct 26, 2002·American Journal of Medical Genetics·Anders MolvenOddmund Søvik
Dec 7, 2002·Diabetes/metabolism Research and Reviews·Jens Juul Holst
Jul 24, 2003·American Journal of Physiology. Endocrinology and Metabolism·Thomas O MundingerGerald J Taborsky

❮ Previous
Next ❯

Citations

Nov 17, 2009·SAR and QSAR in Environmental Research·U Saqib, M I Siddiqi
Oct 28, 2009·Journal of Medicinal Food·Hee Sun Lee, Mi Kyung Kim
Jul 11, 2007·Acta Crystallographica. Section F, Structural Biology and Crystallization Communications·Pengyun LiFaming Zhang
Aug 17, 2011·Diabetes, Obesity & Metabolism·P M Vuguin, M J Charron
Apr 22, 2014·Molecular Metabolism·Joseph ChabenneRichard Dimarchi
Nov 30, 2013·Endocrinology and Metabolism Clinics of North America·Jelena Maletkovic, Andrew Drexler
Sep 14, 2010·Biochemical and Biophysical Research Communications·Mitsuru ShimamuraAkira Shinagawa
Jul 7, 2007·Clinics in Podiatric Medicine and Surgery·Giovanni Ghirlanda, Lorena Mancini
Dec 18, 2009·Nutrition Research and Practice·Hyejin JeongMi Kyung Kim
Apr 18, 2007·Clinical Pharmacology and Therapeutics·W T CefaluS Ryder
Jul 11, 2013·American Journal of Therapeutics·Fuad LechinBetty Pardey-Maldonado
Jun 28, 2020·Journal of Veterinary Internal Medicine·Simon CookChris Scudder

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.